Fortis Healthcare Ltd
₹712.90
-13.75 (1.89%)
Wed, 28 Oct 2026, 02:41 pm
Health Services
Hospital/Nursing Management
24.5KFortis Healthcare Ratios
| Particulars | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 106.25 | 70.19 | 46.40 | 56.32 | 8.10 | 36.22 | 0 | 1350 | 20.30 | 0 | 0 | 164.26 | 0 | 39.49 | 33.33 | 52.93 | 68.11 |
| Price to book ratio | 0 | 0 | 1.65 | 1.46 | 3.09 | 1.87 | 1.25 | 1.09 | 1.06 | 1.88 | 1.95 | 1.81 | 1.58 | 1.55 | 1.43 | 2.45 | 3.55 | 2.71 | 4.14 | 5.91 |
| Price to sales ratio | 0 | 0 | 3.57 | 2.44 | 5.20 | 3.97 | 1.38 | 0.97 | 1.23 | 1.95 | 5.95 | 1.88 | 1.41 | 2.47 | 2.08 | 3.78 | 3.88 | 3.15 | 4.63 | 6.81 |
| Price to cash flow ratio | 0 | 0 | 0 | 66.86 | 45.10 | 0 | 33.75 | 3.69 | 20.65 | 0 | 141.88 | 7.18 | 16.58 | 24 | 324.61 | 36.37 | 28.98 | 27.22 | 30.68 | 38.43 |
| Enterprise value | 0 | 0 | 2209Cr | 1995Cr | 9083Cr | 6792Cr | 11345Cr | 11320Cr | 5873Cr | 9418Cr | 26334Cr | 11011Cr | 9063Cr | 12558Cr | 11389Cr | 16736Cr | 23596Cr | 21036Cr | 33148Cr | 54954Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 114.79 | 22.91 | 63.22 | 95.24 | 30.55 | 37.14 | 185.40 | 93.72 | 139.41 | 32.45 | 26.95 | 50.88 | 19.54 | 42.37 | 23.09 | 20.17 | 26.62 | 34.95 |
| Debt to equity ratio | 1.92 | 1.60 | 0.34 | 0.45 | 2.90 | 0.33 | 2.11 | 1.48 | 0.38 | 0.38 | 0.34 | 0.43 | 0.48 | 0.30 | 0.24 | 0.25 | 0.20 | 0.13 | 0.15 | 0.28 |
| Return on equity % | -36.06 | -28.31 | -7.44 | 1.31 | 4.70 | 4.85 | 2.21 | 12.85 | -5.59 | -2.45 | 0.36 | 8.78 | -21.93 | -5.61 | 0.87 | -1.72 | 9.03 | 8.77 | 8.04 | 9.34 |
Fortis Healthcare Ltd Ratios
The Fortis Healthcare Ltd Ratios page provides a complete fundamental analysis of Fortis Healthcare Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Fortis Healthcare Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.
Fortis Healthcare Ltd (NSE: FORTIS, BSE: 532843) is currently trading at ₹712.90, with a market capitalization of ₹54356.99Cr. As a major player in the Health services sector and Hospital/Nursing management industry, Fortis Healthcare Ltd remains a key stock for fundamental analysis using Fortis Healthcare Ltd Ratios.
Fortis Healthcare Ltd Ratios: Valuation Overview
Price to Earnings Ratio (P/E)
The Fortis Healthcare Ltd P/E ratio currently stands at 68.11, making it one of the most tracked metrics in Fortis Healthcare Ltd Ratios.
Historically, the Fortis Healthcare Ltd P/E ratio has shown strong fluctuations:
- 2025: 68.11
- 2024: 52.93
- 2023: 33.33
- 2022: 39.49
- 2021: 0
The rising Fortis Healthcare Ltd P/E ratio indicates increasing investor confidence and premium valuation.
Price to Book Ratio (P/B)
The Fortis Healthcare Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 5.91.
Historical P/B trend:
- 2025: 5.91
- 2024: 4.14
- 2023: 2.71
- 2022: 3.55
Fortis Healthcare Ltd is trading at a premium to its book value, indicating strong market confidence.
Price to Sales Ratio (P/S)
The Fortis Healthcare Ltd P/S ratio currently stands at 6.81, an important part of Fortis Healthcare Ltd Ratios for revenue valuation.
Historical P/S ratio:
- 2025: 6.81
- 2024: 4.63
- 2023: 3.15
- 2022: 3.88
The rising Fortis Healthcare Ltd P/S ratio indicates improved revenue valuation by investors.
Fortis Healthcare Ltd Price to Cash Flow Ratio (P/CF)
The Fortis Healthcare Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 38.43.
Historical Fortis Healthcare Ltd Price to Cash Flow Ratio:
- 2025: 38.43
- 2024: 30.68
- 2023: 27.22
- 2022: 28.98
- 2021: 36.37
The rising Fortis Healthcare Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.
Fortis Healthcare Ltd Enterprise Value Ratios
Enterprise Value (EV)
The Fortis Healthcare Ltd EV currently stands at ₹54954Cr, representing the total company valuation including debt.
Historical EV trend:
- 2025: 54954Cr
- 2024: 33148Cr
- 2023: 21036Cr
- 2022: 23596Cr
Fortis Healthcare Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.
EV/EBITDA Ratio
The Fortis Healthcare Ltd EV/EBITDA ratio is currently 34.95, a key metric in Fortis Healthcare Ltd Ratios to assess valuation relative to earnings.
Historical EV/EBITDA:
- 2025: 34.95
- 2024: 26.62
- 2023: 20.17
- 2022: 23.09
Higher Fortis Healthcare Ltd EV/EBITDA suggests premium valuation.
Fortis Healthcare Ltd Financial Strength Ratios
Debt to Equity Ratio (D/E)
The Fortis Healthcare Ltd D/E ratio is currently 0.28, reflecting leverage and financial stability.
Historical D/E:
- 2025: 0.28
- 2024: 0.15
- 2023: 0.13
- 2022: 0.20
Fortis Healthcare Ltd maintains a strong balance sheet with low debt levels.
Return on Equity (ROE %)
The Fortis Healthcare Ltd ROE currently stands at 9.34%, showing profitability and capital efficiency.
Historical ROE:
- 2025: 9.34
- 2024: 8.04
- 2023: 8.77
- 2022: 9.03
Declining ROE indicates pressure on profitability.
Fortis Healthcare Ltd Ratios Analysis Summary
The Fortis Healthcare Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Fortis Healthcare Ltd stock is undervalued, fairly valued, or overvalued.
Tracking Fortis Healthcare Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.
